105 results
8-K
EX-10.1
MTNB
Matinas Biopharma Holdings Inc
5 Apr 24
Matinas BioPharma Announces Registered Direct Offering of $10 Million
7:00am
judicially determined to constitute fraud, gross negligence or willful misconduct). The Company will indemnify each Purchaser Party, to the fullest extent
8-K
f68 sl5nhodavxltiw48
22 Sep 23
Matinas BioPharma Announces Notification of NYSE American Continued Listing Deficiency
5:25pm